Why the study?
Does injection of a PV-1/PV-3 hybrid virus elicit neutralizing antibodies against both serotypes in rabbits and monkeys?
Does injection of a PV-1/PV-3 hybrid virus elicit neutralizing antibodies against both serotypes in rabbits and monkeys?
Sequence replacement at N-AgI of poliovirus is compatible with viral proliferation and elicits multivalent neutralizing antibodies, which may be useful for the development of multivalent picornavirus vaccines.
Answers are grounded in this paper and cite their sources.
Animal data support hybrid antigens for multivalent picornavirus vaccines; leaves open human translation and safety.
Poliovirus exists as three stable serotypes (PV-1, PV-2, and PV-3). These viruses display three antigenic sites each, designated N-AgI, N-AgII, and N-AgIII. When mice are immunized with poliovirus, N-AgI is the major neutralization antigenic site for PV-3, whereas N-AgII and N-AgIII are immunodominant over N-AgI for PV-1. To study the relationship between structure and antigenicity, a hybrid virus was constructed in which N-AgI of PV-1 was replaced by N-AgI of PV-3. PV-3- and PV-1-specific antisera, including those elicited by PV-3 in primates, neutralized the hybrid virus. Injection of the hybrid virus into rabbits or into primates resulted in the production of antisera that neutralized both PV-1 and PV-3. The data show that sequence replacement at N-AgI of poliovirus is compatible with viral proliferation, an observation useful for the development of multivalent picornavirus vaccines.
No takes yet. Share an insight, caveat, or question.
Murray et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: